Loading
圓祥生技 Stock: price and insider trades · Taiwan
TW·Mcap NT$13.3B
圓祥生技: what insiders have been doing
圓祥生技 has a thin disclosure history in our data (latest filing: 29 May 2026). New filings will appear here as soon as they are published. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
NT$137
Analyst consensus
Income statement
EBITDA-NT$417.8M
Net income-NT$444.8M0.0% margin
Valuation
P/Book5.7x
Beta-0.34
Balance sheet & cash
Market capNT$13.3B
Total debtNT$59.5M
Free Cash Flow-NT$377.3M
Debt / Equity2%
Profitability & ownership
ROE-24.5%
ROA-16.3%
% insiders47.2%
% institutions4.0%
Last declaration on 29 May 2026
Declarations1 total
500,000 sharesShareTPExTWMOPS:6945:115/05/29:台灣浩鼎生技股份有限公司:1363xh7
1 of 1 declaration
About 圓祥生技
圓祥生技 is a company listed on the XTAI, specializing in the biotechnology sector. It focuses on developing innovative health solutions.